Latest filing published 18 Sept 2014 for Protalix BioTherapeutics, Inc..
Insider track record
No signal scores available.
Bio-Cell Ltd: trading record in brief
This profile gathers the share dealings of Bio-Cell Ltd in Protalix BioTherapeutics, Inc. Over a trading history stretching from 31 December 2006 to 16 September 2014, the count stands at 3 filings.
No open-market purchase appears, only 1 sale worth €8.1M. Outside the open market, there are 1 share grant. In 2014 alone, the filings show no purchases and 1 sale.
The record was last updated on 18 September 2014 with a transaction in Protalix BioTherapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Bio-Cell Ltd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,556,371 sharesCommon StockSEC:0001178913-14-002976:0
- 14,466,319 sharesCommon StockSEC:0001209191-07-002544:0
2 of 2 declarations
